eISSN: 1731-2531
ISSN: 1642-5758
Anaesthesiology Intensive Therapy
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2020
vol. 52
 
Share:
Share:
abstract:
Review article

COVID-19 and haemodynamic failure: a point of view on mechanisms and treatment

Tomasz Jasiński
1
,
Jan Stefaniak
1

1.
Department of Anaesthesiology and Intensive Therapy, Medical University of Gdansk, Poland
Anaesthesiol Intensive Ther 2020; 52, 5: 409–417
Online publish date: 2020/12/15
View full text Get citation
 
PlumX metrics:
The SARS-CoV-2-related disease has an undoubted impact on the healthcare system. In the treatment of severe COVID-19 cases, the main focus is on respiratory failure. However, available data suggest an important contribution of haemodynamic impairment in the course of this disease. SARS-CoV-2 may affect the circulatory system in various ways that are universal for septic conditions. Nonetheless, unique features of this pathogen, e.g. direct insult leading to myocarditis and renin-angiotensin-aldosterone axis dysregulation, must be taken into account. Although current recommendations on COVID-19 resemble previous septic shock guidelines, special attention to haemodynamic monitoring and treatment is necessary. Regarding treatment, one must take into account the potential profound hypovolaemia of severe COVID-19 patients. Pharmacological cardiovascular support should follow existing guidelines and practice. Interesting concepts of decatecholaminisation and the effect of vasopressors on pulmonary circulation are also presented in this review on COVID-19-related haemodynamic failure.
keywords:

hemodynamics, COVID-19, critical care, SARS-CoV-2, cardiovascular

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.